These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36320059)

  • 21. Sex and the Relationship Between Cardiometabolic Risk Factors and Estimated GFR Decline: A Population-Based Cohort Study.
    Sullivan MK; Lees JS; Rosales BM; Cutting R; Wyld ML; Woodward M; Webster AC; Mark PB; De La Mata N
    Am J Kidney Dis; 2024 Dec; 84(6):731-741.e1. PubMed ID: 39053834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants.
    Trevisan M; Hjemdahl P; Clase CM; de Jong Y; Evans M; Bellocco R; Fu EL; Carrero JJ
    Am J Kidney Dis; 2023 Mar; 81(3):307-317.e1. PubMed ID: 36208798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired renal function is associated with recurrence after cryoballoon catheter ablation for paroxysmal atrial fibrillation: A potential effect of non-pulmonary vein foci.
    Yanagisawa S; Inden Y; Kato H; Fujii A; Mizutani Y; Ito T; Kamikubo Y; Kanzaki Y; Ando M; Hirai M; Shibata R; Murohara T
    J Cardiol; 2017 Jan; 69(1):3-10. PubMed ID: 27499270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
    Neuen BL; Ohkuma T; Neal B; Matthews DR; de Zeeuw D; Mahaffey KW; Fulcher G; Blais J; Li Q; Jardine MJ; Perkovic V; Wheeler DC
    Am J Kidney Dis; 2021 Jan; 77(1):23-34.e1. PubMed ID: 32971190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct Comorbidity Clusters in Patients With Acute Heart Failure: Data From RELAX-AHF-2.
    Gomez KA; Tromp J; Figarska SM; Beldhuis IE; Cotter G; Davison BA; Felker GM; Gimpelewicz C; Greenberg BH; Lam CSP; Voors AA; Metra M; Teerlink JR; van der Meer P
    JACC Heart Fail; 2024 Oct; 12(10):1762-1774. PubMed ID: 38970586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic Kidney Disease Predicts Adverse Major Cardiovascular Events and Adverse Limb Events in Patients With Diabetes and Peripheral Arterial Disease.
    Rerkasem A; Mangklabruks A; Buranapin S; Sony K; Inpankaew N; Rerkasem R; Pongtam S; Phirom K; Rerkasem K
    Int J Low Extrem Wounds; 2024 Mar; 23(1):19-26. PubMed ID: 37920918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTs.
    Ferreira JP; Pitt B; McMurray JJV; Pocock SJ; Solomon SD; Pfeffer MA; Zannad F; Rossignol P
    JACC Heart Fail; 2022 Nov; 10(11):842-850. PubMed ID: 36328653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospitalisation events in people with chronic kidney disease as a component of multimorbidity: parallel cohort studies in research and routine care settings.
    Sullivan MK; Jani BD; McConnachie A; Hanlon P; McLoone P; Nicholl BI; Carrero JJ; Nitsch D; McAllister D; Mair FS; Mark PB
    BMC Med; 2021 Nov; 19(1):278. PubMed ID: 34794437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort.
    Dal Canto E; Elders PJM; van der Heijden AA; van Ballegooijen AJ; Lissenberg-Witte BI; Rutters F; Beulens JWJ
    Diabetologia; 2023 Mar; 66(3):482-494. PubMed ID: 36347992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
    Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney Dysfunction and the Risk of Developing Aortic Stenosis.
    Vavilis G; Bäck M; Occhino G; Trevisan M; Bellocco R; Evans M; Lindholm B; Szummer K; Carrero JJ
    J Am Coll Cardiol; 2019 Jan; 73(3):305-314. PubMed ID: 30678761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.
    Posch F; Ay C; Stöger H; Kreutz R; Beyer-Westendorf J
    Int J Cardiol; 2019 May; 282():47-52. PubMed ID: 30777405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
    McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
    Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fractures and their sequelae in non-dialysis-dependent chronic kidney disease: the Stockholm CREAtinine Measurement project.
    Runesson B; Trevisan M; Iseri K; Qureshi AR; Lindholm B; Barany P; Elinder CG; Carrero JJ
    Nephrol Dial Transplant; 2020 Nov; 35(11):1908-1915. PubMed ID: 31361316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular Events after New-Onset Atrial Fibrillation in Adults with CKD: Results from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Bansal N; Xie D; Sha D; Appel LJ; Deo R; Feldman HI; He J; Jamerson K; Kusek JW; Messe S; Navaneethan SD; Rahman M; Ricardo AC; Soliman EZ; Townsend R; Go AS
    J Am Soc Nephrol; 2018 Dec; 29(12):2859-2869. PubMed ID: 30377231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trials.
    Sacre JW; Magliano DJ; Shaw JE
    Diabetes Metab; 2021 Sep; 47(5):101249. PubMed ID: 33744399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial.
    Wheeler DC; Stefánsson BV; Jongs N; Chertow GM; Greene T; Hou FF; McMurray JJV; Correa-Rotter R; Rossing P; Toto RD; Sjöström CD; Langkilde AM; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Jan; 9(1):22-31. PubMed ID: 33338413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kidney Function, Proteinuria, and Cancer Incidence: The Korean Heart Study.
    Mok Y; Matsushita K; Ballew SH; Sang Y; Jung KJ; Lee S; Jee SH; Coresh J
    Am J Kidney Dis; 2017 Oct; 70(4):512-521. PubMed ID: 28601406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of the diabetes-cardio-renal spectrum: a cross-sectional report of 1.4 million adults.
    Schechter M; Melzer Cohen C; Yanuv I; Rozenberg A; Chodick G; Bodegård J; Leiter LA; Verma S; Lambers Heerspink HJ; Karasik A; Mosenzon O
    Cardiovasc Diabetol; 2022 Jun; 21(1):104. PubMed ID: 35689214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.